Premium Nahrungsergänzungsmittel | artgerecht

cDC1 - Type 1 Conventional Dendritic Cells

cDC1 (type 1 conventional dendritic cells) are specialized immune cells that play a key role in activating cytotoxic T cells and driving anti-tumor immunity.

Regular tips about health Regular tips about health

Things worth knowing about "cDC1"

cDC1 (type 1 conventional dendritic cells) are specialized immune cells that play a key role in activating cytotoxic T cells and driving anti-tumor immunity.

What are cDC1 Cells?

cDC1 (type 1 conventional dendritic cells) are a specialized subset of dendritic cells belonging to the innate immune system. They are part of the myeloid immune cell lineage and are distinguished by their unique ability to present antigens via cross-presentation on MHC class I molecules. This allows them to prime and activate cytotoxic CD8+ T lymphocytes, which are critical for eliminating tumor cells and virus-infected cells.

Biological Characteristics and Markers

cDC1 cells are identified by specific surface markers that differ slightly between species:

In humans: Expression of CLEC9A (DNGR-1), XCR1, CADM1, and CD141 (BDCA-3)
In mice: Expression of CD8α (in lymphoid organs) and CD103 (in peripheral tissues), along with XCR1 and CLEC9A

These markers clearly distinguish cDC1 cells from the second conventional dendritic cell subset, cDC2 cells, and from plasmacytoid dendritic cells (pDC).

Development and Differentiation

cDC1 cells develop from hematopoietic progenitor cells in the bone marrow. Their differentiation depends critically on specific transcription factors:

IRF8 (Interferon Regulatory Factor 8): The master regulator of cDC1 development
BATF3: Essential for the maturation of cDC1 cells in both lymphoid and non-lymphoid tissues
ID2: Supports the commitment to the cDC1 lineage

The cytokine Flt3 ligand (Flt3L) serves as a key growth factor for the development and homeostatic maintenance of cDC1 cells.

Function in the Immune System

The main functions of cDC1 cells include:

Cross-presentation: Uptake of extracellular or cellular antigens (e.g., from dead tumor cells) and their presentation on MHC class I molecules to activate CD8+ T cells
Cytotoxic T cell priming: Initiation of anti-tumor and antiviral CD8+ T cell responses
Cytokine production: Secretion of IL-12, which drives Th1 immune responses and activates natural killer (NK) cells
XCL1-XCR1 axis: Interaction with XCL1-secreting NK and CD8+ T cells via the XCR1 receptor to amplify immune responses

Role in Cancer and Immunotherapy

cDC1 cells are of particular importance in tumor immunology. Studies show that a high density of cDC1 cells within tumors correlates with improved clinical outcomes across multiple cancer types, including melanoma, colorectal cancer, and breast cancer.

In the context of cancer immunotherapy, cDC1 cells play a crucial role:

They are required for the efficacy of immune checkpoint inhibitors (e.g., anti-PD-1, anti-CTLA-4)
They support the effectiveness of adoptive T cell transfer and cancer vaccines
They are involved in the abscopal effect of radiotherapy, in which locally irradiated tumors also cause regression of distant metastases

Therefore, strategies to expand or enhance cDC1 cells represent a promising approach in cancer immunotherapy research.

Clinical and Therapeutic Relevance

Because cDC1 cells are rare in the blood and within tumors, various approaches are being investigated to increase their numbers and function:

Administration of Flt3L to expand cDC1 cells in vivo
In vitro generation of cDC1-like cells from progenitor cells for cell-based therapies
Use of cDC1 activators such as TLR3 and TLR9 agonists to boost immune responses
Development of bispecific antibodies that bring cDC1 cells into direct contact with tumor cells

References

Guilliams M, Ginhoux F, Jakubzick C, et al. - Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nature Reviews Immunology, 2014; 14(8): 571–578.
Hildner K, Edelson BT, Purtha WE, et al. - Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science, 2008; 322(5904): 1097–1100.
Brown CC, Gudjonson H, Pritykin Y, et al. - Transcriptional Basis for Frequent Failures in Intestinal Barrier Function with Advanced Age. Cell Reports, 2019; 27(1): 17–33.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.